Hi waynesworld, how could the Phenomica spinoff be used as a template for PYC to give PYC any commercial benefit, at least in the short-term?
As far as I know Phenomica has not yet produced any commercial benefit for PYC and frankly PYC needs a significant commercial transaction to occur SOON if it wants to remain viable.
Any talk of Phenomica as a template is more than a little academic at this point in time.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.36 |
Change
0.005(0.37%) |
Mkt cap ! $793.2M | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.40 | $1.36 | $211.9K | 152.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4103 | $1.36 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.39 | 2028 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |